GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 767 filers reported holding GLAXOSMITHKLINE PLC in Q4 2016. The put-call ratio across all filers is 1.34 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2019 | $271,000 | -13.7% | 5,767 | -21.7% | 0.14% | -16.3% |
Q3 2019 | $314,000 | -9.0% | 7,367 | -14.6% | 0.17% | +3.1% |
Q2 2019 | $345,000 | -22.5% | 8,629 | -18.9% | 0.16% | -26.8% |
Q1 2019 | $445,000 | +17.7% | 10,637 | +7.6% | 0.22% | +4.8% |
Q4 2018 | $378,000 | +10.9% | 9,883 | +16.8% | 0.21% | +5.5% |
Q2 2018 | $341,000 | -15.8% | 8,460 | -18.4% | 0.20% | -15.0% |
Q1 2018 | $405,000 | -8.2% | 10,372 | -16.6% | 0.23% | -19.3% |
Q4 2017 | $441,000 | -15.5% | 12,430 | -3.3% | 0.29% | -16.9% |
Q3 2017 | $522,000 | +63.6% | 12,851 | +73.8% | 0.35% | +60.8% |
Q2 2017 | $319,000 | -9.1% | 7,395 | -11.1% | 0.22% | -9.2% |
Q1 2017 | $351,000 | -32.1% | 8,316 | -38.0% | 0.24% | -35.8% |
Q4 2016 | $517,000 | +56.7% | 13,416 | +75.5% | 0.37% | +58.3% |
Q3 2016 | $330,000 | +0.9% | 7,644 | +1.4% | 0.24% | +2.6% |
Q2 2016 | $327,000 | -28.1% | 7,541 | -32.8% | 0.23% | -30.4% |
Q1 2016 | $455,000 | +64.9% | 11,220 | +64.2% | 0.33% | +46.9% |
Q4 2015 | $276,000 | – | 6,833 | – | 0.22% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Black Creek Investment Management Inc. | 7,951,626 | $318,224,000 | 10.49% |
Healthcare Value Capital, LLC | 120,000 | $4,802,000 | 9.01% |
KAHN BROTHERS GROUP INC | 1,605,014 | $64,232,661,000 | 8.03% |
Eversept Partners, LP | 693,685 | $28,091,890 | 7.87% |
EQUITY INVESTMENT CORP | 2,673,764 | $107,004,000 | 3.74% |
Sio Capital Management, LLC | 379,500 | $15,188,000 | 3.66% |
Martin Capital Partners, LLC | 115,448 | $4,620,000 | 3.27% |
Circle Road Advisors LP | 53,028 | $2,122,000 | 3.10% |
Keystone Financial Planning, Inc. | 156,968 | $6,282,000 | 3.07% |
CAMG Solamere Management, LLC | 160,294 | $6,415,000 | 2.94% |